The healthcare industry’s transition toward value-based care has long been framed through the lens of reimbursement reform, but Lakshmi Halasyamani, M.D., Chief Clinical Officer at Endeavor Health, argues that this perspective is fundamentally flawed. Speaking on the current state of the industry, Halasyamani emphasized that value-based care (VBC) has become one of the most misunderstood […]
Prior authorization, once a localized administrative hurdle designed to control healthcare costs, has evolved into one of the industry’s most significant financial and operational bottlenecks. What began as a tool for insurers to ensure medical necessity has transformed into a complex web of requirements that affects hospital systems, physician practices, and, most critically, patient outcomes. […]
The American healthcare landscape is currently undergoing a seismic shift in its underlying economic foundations, forcing community and mid-sized hospitals to navigate an increasingly treacherous financial environment. For decades, these institutions relied on a predictable "cross-subsidization" model, where higher reimbursements from commercial insurance providers effectively covered the shortfalls generated by government payers and uncompensated care. […]
Crystalys Therapeutics, a San Diego-based biopharmaceutical company focused on the development of transformative treatments for metabolic and inflammatory diseases, has announced the successful closing of a $130 million Series B financing round. This significant capital infusion, led by Frazier Life Sciences, arrives less than a year after the company emerged from stealth with a $205 […]
Candid Health, a San Francisco-based developer of autonomous revenue cycle management (RCM) technology, announced on Wednesday that it has successfully closed a $120 million Series D funding round. The investment was led by Sixth Street Growth, with significant participation from existing investors including Oak HC/FT, 8VC, and Y Combinator. This latest capital infusion comes less […]
The modern emergency department serves as the primary safety net for the American healthcare system, yet the metrics used to define its success are increasingly viewed as ill-suited for the growing volume of behavioral health crises. Two patients who present in the emergency department in identical ways can have very different treatment experiences, even if […]
The landscape of healthcare venture investing is undergoing a fundamental structural transformation, shifting from a model of reactive evaluation to one of proactive scientific discovery. For decades, the primary objective of healthcare investors was to identify the most promising startups within an established ecosystem. However, the coming decade is expected to favor a new breed […]
The rapid integration of artificial intelligence into the healthcare sector is forcing a fundamental reassessment of how identity is defined, verified, and managed. While the initial wave of AI adoption focused on improving clinical efficiency and diagnostic accuracy for providers, the industry is now approaching a critical juncture where AI agents will take on autonomous […]
The United States pharmaceutical landscape is currently defined by a stark and widening paradox: while scientific innovation is delivering groundbreaking cures at an unprecedented rate, the systems required to pay for and distribute these medicines are becoming increasingly fractured. Despite an annual national expenditure exceeding $800 billion on pharmaceuticals, a significant portion of the American […]
The landscape of digital health investment is undergoing a fundamental shift as venture capitalists move away from backing charismatic visionaries with "fix-it-all" mentalities toward founders who demonstrate deep self-awareness, operational discipline, and a willingness to pivot. During a featured panel discussion this week at MedCity News’ Bullseye event in Chicago, prominent investors from Town Hall […]
